Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry

INTRODUCTION: Similar outcomes have been observed between patients with rheumatoid arthritis (RA) responding to tocilizumab (TCZ) with methotrexate (MTX) who discontinued vs. continued MTX and between patients receiving MTX who added TCZ vs. switched to TCZ monotherapy. This study examined MTX disco...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Rheumatol Ther
Glavni autori: Pappas, Dimitrios A., Blachley, Taylor, Zlotnick, Steve, Best, Jennie, Emeanuru, Kelechi, Kremer, Joel M.
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7211217/
https://ncbi.nlm.nih.gov/pubmed/32232740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-020-00200-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items